X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (409) 409
Publication (13) 13
Patent (6) 6
Book Review (4) 4
Book Chapter (3) 3
Conference Proceeding (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (196) 196
animals (163) 163
male (104) 104
oxidative stress (103) 103
humans (86) 86
rats (84) 84
heart (71) 71
obesity (70) 70
rats, wistar (70) 70
insulin resistance (65) 65
cardiac & cardiovascular systems (57) 57
apoptosis (53) 53
mitochondria (53) 53
insulin (51) 51
ischemia (49) 49
rodents (49) 49
female (44) 44
endocrinology & metabolism (41) 41
pharmacology & pharmacy (41) 41
cardiovascular (34) 34
brain (32) 32
physiology (31) 31
medicine, research & experimental (30) 30
analysis (29) 29
mice (29) 29
swine (29) 29
disease models, animal (28) 28
metabolism (28) 28
physiological aspects (28) 28
cardiomyopathy (27) 27
high-fat diet (26) 26
mitochondria - drug effects (25) 25
dysfunction (24) 24
inflammation (24) 24
internal medicine (24) 24
oxidative stress - drug effects (24) 24
thalassemia (24) 24
cell biology (23) 23
metabolic syndrome (23) 23
obesity - physiopathology (23) 23
heart diseases (22) 22
heart rate (22) 22
myocardial-infarction (22) 22
expression (21) 21
glucose (21) 21
reperfusion (21) 21
vildagliptin (21) 21
mitochondrial dna (20) 20
mitochondrial dysfunction (20) 20
treatment outcome (20) 20
adamantane - analogs & derivatives (19) 19
antioxidants (19) 19
heart rate - drug effects (19) 19
heart-rate-variability (19) 19
high fat diet (19) 19
obesity - metabolism (19) 19
cardiac function (18) 18
cognition (18) 18
insulin resistance - physiology (18) 18
mitochondria - metabolism (18) 18
neurophysiology (18) 18
research (18) 18
brain - metabolism (17) 17
defibrillation (17) 17
diet, high-fat (17) 17
disease (17) 17
health aspects (17) 17
heart - drug effects (17) 17
ischemia-reperfusion injury (17) 17
mortality (17) 17
neurosciences (17) 17
reperfusion injury (17) 17
adult (16) 16
arrhythmia (16) 16
diet (16) 16
dipeptidyl-peptidase iv inhibitors - pharmacology (16) 16
electric countershock (16) 16
fibrillation (16) 16
heart beat (16) 16
insulin-resistance (16) 16
iron overload (16) 16
myocardial infarction (16) 16
neurology (16) 16
nutrition & dietetics (16) 16
obesity - complications (16) 16
reactive oxygen species - metabolism (16) 16
activation (15) 15
biochemistry & molecular biology (15) 15
cardiology (15) 15
cardiotonic agents - pharmacology (15) 15
care and treatment (15) 15
heart - physiopathology (15) 15
hematology (15) 15
myocardium - metabolism (15) 15
myocardium - pathology (15) 15
prevention (15) 15
universities and colleges (15) 15
adamantane - pharmacology (14) 14
apoptosis - drug effects (14) 14
diabetes (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental Physiology, ISSN 0958-0670, 09/2017, Volume 102, Issue 9, pp. 1044 - 1045
Journal Article
Experimental Physiology, ISSN 0958-0670, 09/2017, Volume 102, Issue 9, pp. 1044 - 1045
Journal Article
Experimental Neurology, ISSN 0014-4886, 02/2020, Volume 324, p. 113118
Journal Article
Pharmacological Research, ISSN 1043-6618, 01/2020, Volume 151, p. 104542
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 11/2017, Volume 21, Issue 11, pp. 2643 - 2653
The current therapeutic strategy for the management of acute myocardial infarction (AMI) is to return blood flow into the occluded coronary artery of the... 
mitochondrial fission | mitochondrial fusion | heart | mitochondrial dynamics | ischaemia reperfusion injury | MEDICINE, RESEARCH & EXPERIMENTAL | FUSION | MYOCARDIAL-INFARCTION | DRP1 | PROTECTS | CELL BIOLOGY | ISCHEMIA-REPERFUSION INJURY | INHIBITION | CALCINEURIN | FISSION | DYSFUNCTION | Mitochondria, Heart - metabolism | Humans | Peptide Fragments - pharmacology | Mitochondria, Heart - drug effects | Myocardial Reperfusion Injury - pathology | Myocardial Infarction - pathology | Myocardium - metabolism | Tacrolimus - pharmacology | Myocardial Reperfusion Injury - drug therapy | Quinazolinones - pharmacology | Disease Models, Animal | Cell Line | Ventricular Function, Left - drug effects | Myocardium - pathology | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Hydrazones - pharmacology | Myocardial Reperfusion Injury - metabolism | Myocytes, Cardiac - pathology | Animals | Mitochondrial Dynamics - drug effects | Myocardial Infarction - drug therapy | Myocytes, Cardiac - drug effects | Myocytes, Cardiac - metabolism | GTP Phosphohydrolases - pharmacology | Cardiac patients | Analysis | Myocardial infarction | Heart | Drugs | Coronary artery | Pharmacology | Mitochondrial DNA | Patients | Fission | Promoters | Modulators | Blood flow | Quality of life | Mitochondria | Reperfusion | Ischemia | Infarction | Heart diseases | Injuries | Reviews | Review
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2013, Volume 169, Issue 5, pp. 1048 - 1057
Background and Purpose Long‐term high‐fat diet (HFD) consumption has been shown to cause insulin resistance, which is characterized by hyperinsulinaemia with... 
high‐fat diet | cardiac function | sitagliptin | vildagliptin | insulin resistance | high-fat diet | SURVIVAL | MODEL | LIPOPROTEIN | INFARCTION | IV INHIBITOR SITAGLIPTIN | DPP-4 INHIBITION | GLUCAGON-LIKE PEPTIDE-1 | IMPROVES | PHARMACOLOGY & PHARMACY | DYSFUNCTION | Body Weight | Reactive Oxygen Species - metabolism | Nitriles - pharmacology | Obesity - drug therapy | Rats, Wistar | Cholesterol - blood | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Heart - physiology | Diet, High-Fat - adverse effects | Male | Pyrazines - therapeutic use | Mitochondria, Heart - drug effects | Insulin - blood | Membrane Potential, Mitochondrial - drug effects | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Cardiotonic Agents - therapeutic use | Heart Rate - drug effects | Malondialdehyde - blood | Adamantane - therapeutic use | Blood Pressure - drug effects | Sitagliptin Phosphate | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Malondialdehyde - metabolism | Adamantane - pharmacology | Blood Glucose - analysis | Insulin Resistance | Obesity - physiopathology | Cardiotonic Agents - pharmacology | Obesity - metabolism | Triazoles - pharmacology | Animals | Mitochondria, Heart - physiology | Heart - drug effects | Oxidative Stress - drug effects | Pyrazines - pharmacology | Nitriles - therapeutic use | Heart | Obesity | Heart beat | Body weight | Insulin resistance | Insulin | Cholesterol | Research Papers
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e85115
Background: Excessive iron accumulation leads to iron toxicity in the brain; however the underlying mechanism is unclear. We investigated the effects of iron... 
OVERLOAD | LIPID-PEROXIDATION | INSULIN-RECEPTOR FUNCTION | INDUCED OXIDATIVE STRESS | MULTIDISCIPLINARY SCIENCES | MITOCHONDRIAL DYSFUNCTION | INFLAMMATION ALTERS | EXPERIMENTAL STROKE | N-ACETYLCYSTEINE | SYNAPTIC PLASTICITY | RECOGNITION MEMORY IMPAIRMENT | Iron Overload - drug therapy | Oxidative Stress | Diet - adverse effects | Male | Cognition | Brain Diseases - physiopathology | Brain - metabolism | Brain Diseases - drug therapy | Iron Chelating Agents - administration & dosage | Brain Diseases - etiology | Drug Therapy, Combination | Disease Models, Animal | Brain - physiopathology | Rats | Treatment Outcome | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondria - pathology | Iron - metabolism | Blood-Brain Barrier - metabolism | Brain - drug effects | Iron Overload - complications | Animals | Maze Learning | Antioxidants - administration & dosage | Brain - pathology | Apoptosis | Antioxidants | Brain | Cysteine | Research | Cystine | Therapy | Oxidative stress | Multiple sclerosis | Toxicity | Memory | Homeostasis | Nervous system | Iron | Accumulation | Training | Learning | Mitochondria | Blood-brain barrier | Neurodegeneration | Rodents | Plasticity | Physiology | Consumption | Inflammation | Metabolism | Medicine | Studies | Brain research | Plasticity (synaptic) | Diet | Laboratory animals
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 07/2018, Volume 17, Issue 1, pp. 101 - 17
Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium-glucose... 
Heart | Diabetes mellitus | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | SGLT2 INHIBITORS | NLRP3 INFLAMMASOME ACTIVATION | HEART-FAILURE | ENDOPLASMIC-RETICULUM STRESS | NA+/H+-EXCHANGER | TYPE-2 DIABETIC-PATIENTS | CARDIAC-HYPERTROPHY | ENDOCRINOLOGY & METABOLISM | KETONE-BODY METABOLISM | REG OUTCOME TRIAL | Diabetic Cardiomyopathies - mortality | Humans | Heart Failure - physiopathology | Myocardial Contraction - drug effects | Heart Failure - blood | Diabetic Cardiomyopathies - physiopathology | Protective Factors | Heart Failure - prevention & control | Myocardium - metabolism | Diabetic Cardiomyopathies - prevention & control | Diabetic Cardiomyopathies - blood | Heart Failure - mortality | Ventricular Function - drug effects | Heart - physiopathology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Risk Factors | Myocardium - pathology | Treatment Outcome | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 2 - mortality | Heart - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Drugs | Oxidative stress | Heart attacks | Cardiomyopathy | Myocardial ischemia | Glucose | Confidence intervals | Hyperglycemia | Mitochondria | Ischemia | Rodents | Population | Heart diseases | Glucose transporter | Heart failure | Stroke | Complications | Pulmonary arteries | Mortality | Health risks | Risk reduction | Metabolism | Patients | Heart rate | Inhibitors | Sodium | Diabetes | Cardiovascular diseases | Endoplasmic reticulum | Transporter | Apoptosis | Sodium–glucose co-transporter 2 (SGLT-2) inhibitors
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 212 - 212
  Results: Of all treatments, only 252 μg/kg HNG given during the ischemic period increased HN levels in the ischemic myocardium (Figure panel A), decreased... 
Cardiovascular | Internal Medicine | Ischemia | Rodents | Mitochondrial DNA
Journal Article
Archives of Oral Biology, ISSN 0003-9969, 01/2020, Volume 109, p. 104574
Fibroblast growth factors (FGFs) are growth factors that play an important role in tooth development, repair, and regeneration. Of the FGF families, basic... 
Dentin | Wound healing | bFGF | Dental pulp
Journal Article
Evidence-based Complementary and Alternative Medicine, ISSN 1741-427X, 2015, Volume 2015, pp. 593902 - 11
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e102374
Background: Obese-insulin resistance caused by long-term high-fat diet (HFD) consumption is associated with left ventricular (LV) dysfunction and increased... 
OXIDATIVE STRESS | CONNEXIN-43 | INHIBITION | MYOCARDIAL-INFARCTION | HEART-RATE-VARIABILITY | PROTEIN-KINASE | MULTIDISCIPLINARY SCIENCES | MITOCHONDRIA | MODEL | ARRHYTHMIA | ISCHEMIA/REPERFUSION | Metformin - therapeutic use | Nitriles - pharmacology | Rats, Wistar | Calcium - metabolism | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Male | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Cardiotonic Agents - therapeutic use | Heart Rate - drug effects | Myocardial Reperfusion Injury - pathology | Drug Interactions | Adamantane - therapeutic use | Myocardial Reperfusion Injury - drug therapy | Adamantane - analogs & derivatives | Adamantane - pharmacology | Intracellular Space - drug effects | Obesity - complications | Metformin - pharmacology | Insulin Resistance | Rats | Cardiotonic Agents - pharmacology | Mitochondria - drug effects | Mitochondria - pathology | Myocardial Reperfusion Injury - physiopathology | Myocardial Reperfusion Injury - metabolism | Arrhythmias, Cardiac - drug therapy | Animals | Ventricular Dysfunction, Left - drug therapy | Intracellular Space - metabolism | Myocardial Ischemia - complications | Arrhythmias, Cardiac - complications | Nitriles - therapeutic use | Obesity | Heart beat | Arrhythmia | Ischemia | Insulin resistance | Metformin | Insulin | Heart attack | Diabetes therapy | Myocardial infarction | Drugs | Oxidative stress | Plasma | Fourier transforms | Heart attacks | Bax protein | Calcium | Bcl-2 protein | Connexin 43 | Kinases | Subgroups | High fat diet | Training | Proteins | Mitochondria | Reperfusion | Rodents | Physiology | Injuries | Parameters | Mortality | Metabolism | Calcium (mitochondrial) | Medicine | Heart rate | Diet | Infarction | Ventricle | Diabetes | Apoptosis
Journal Article
Journal of Neuroendocrinology, ISSN 0953-8194, 10/2019, Volume 31, Issue 10, pp. e12779 - n/a
Lipocalin‐2 (LCN2) has been known to play an important role in pathological conditions, specifically in response to inflammation, infection and injury to... 
lipocalin‐2 | cognition | neutrophil gelatinase-associated lipocalin | cognitive dysfunction | NGAL | CYTOKINES | RAT | MECHANISMS | GELATINASE-ASSOCIATED LIPOCALIN | NEUROSCIENCES | CELL-DEATH | IMPAIRMENT | HIPPOCAMPUS | INFLAMMATION | ENDO